Literature DB >> 8537189

Delayed macular choriocapillary circulation in age-related macular degeneration.

J Zhao1, D A Frambach, P P Lee, M Lee, P F Lopez.   

Abstract

PURPOSE: To investigate the macular choriocapillary circulation (MCC) in eyes with age-related macular degeneration (ARMD) and to correlate these findings with the associated clinical and angiographic drusen characteristics.
METHODS: Scanning laser ophthalmoscope fluorescein videoangiography was performed on 34 eyes with age-related macular degeneration and eight age-matched normal volunteers. Drusen characteristics were assessed using the Wisconsin age-related maculopathy grading scale.
RESULTS: A delayed macular choriocapillary circulation (DMCC) was defined as a macular choriocapillary filling time greater than 3 standard deviations from the normal mean (greater than 5 seconds). Nine (26%) of the 34 eyes with ARMD were found to have a DMCC. After age adjustment, eyes with DMCC were more likely to have geographic atrophy of the retinal pigment epithelium (p = 0.003) or choroidal neovascularization p = 0.07) than were eyes with a normal MCC. Regional differences in choriocapillary filling times were present in the eyes with a DMCC, including nasal-to-temporal, central-to-peripheral, and inferior-to-superior gradients of progressively less choriocapillary filling delay. The DMCC correlated with the location, number, size, confluence, and fluorescein staining characteristics of the associated drusen.
CONCLUSION: DMCC occurs in some eyes with ARMD. This finding may not only assist in defining eyes at risk for progressive disease but may also help to elucidate the pathogenesis of age-related macular degeneration.

Entities:  

Mesh:

Year:  1995        PMID: 8537189     DOI: 10.1007/bf00156412

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  33 in total

1.  The Framingham Eye Study. I. Outline and major prevalence findings.

Authors:  H A Kahn; H M Leibowitz; J P Ganley; M M Kini; T Colton; R S Nickerson; T R Dawber
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

2.  Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration.

Authors:  P F Lopez; H M Lambert; H E Grossniklaus; P Sternberg
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

3.  Drusen and disciform macular detachment and degeneration.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1973-09

4.  Fluorescein studies of normal choroidal circulation.

Authors:  D Archer; A E Krill; F W Newell
Journal:  Am J Ophthalmol       Date:  1970-04       Impact factor: 5.258

Review 5.  Retinal pigment epithelial detachments in the elderly.

Authors:  A C Bird; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1986

6.  Physiological anatomy of the choroidal vascular bed.

Authors:  S S Hayreh
Journal:  Int Ophthalmol       Date:  1983-02       Impact factor: 2.031

7.  Aging changes in Bruch's membrane. A histochemical and morphologic study.

Authors:  D Pauleikhoff; C A Harper; J Marshall; A C Bird
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

8.  Digital indocyanine green videoangiography and choroidal neovascularization.

Authors:  L A Yannuzzi; J S Slakter; J A Sorenson; D R Guyer; D A Orlock
Journal:  Retina       Date:  1992       Impact factor: 4.256

9.  Fluorescein angiography of the choroid in health and disease.

Authors:  J J De Laey
Journal:  Int Ophthalmol       Date:  1983-02       Impact factor: 2.031

10.  Choroidal ischemia.

Authors:  A Gaudric; G Coscas; A C Bird
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

View more
  9 in total

Review 1.  Age-related changes in retrobulbar circulation: a literature review.

Authors:  Marta P Wiącek; Monika Modrzejewska; Daniel Zaborski
Journal:  Int Ophthalmol       Date:  2019-10-01       Impact factor: 2.031

2.  Choroidal perfusion perturbations in non-neovascular age related macular degeneration.

Authors:  Thomas A Ciulla; Alon Harris; Larry Kagemann; Ronald P Danis; Linda M Pratt; Hak S Chung; Dov Weinberger; Hanna J Garzozi
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

Review 3.  Current and future treatment options for nonexudative and exudative age-related macular degeneration.

Authors:  Grant M Comer; Thomas A Ciulla; Mark H Criswell; Michael Tolentino
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Retinal circulation and its role in macular disorders in patients without systemic disease.

Authors:  Priyangshu Chandra; Aditya Sudhalkar; Souvik Mandal; Jay Chhablani
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration.

Authors:  A Harris; T A Ciulla; L M Pratt; E Rechtman; L Kagemann; H C Piper; H J Garzozi
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

6.  Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.

Authors:  Jose S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  2002

7.  The effect of intravitreal bevacizumab (Avastin) on ocular pulse amplitude in neovascular age-related macular degeneration.

Authors:  Ehud Rechtman; Ingeborg Stalmans; Joseph Glovinsky; Christophe Breusegem; Joseph Moisseiev; Joachim Van Calster; Alon Harris
Journal:  Clin Ophthalmol       Date:  2011-01-06

8.  CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits.

Authors:  Emilie Picard; Marianne Houssier; Kim Bujold; Przemyslaw Sapieha; William Lubell; Allison Dorfman; Julie Racine; Pierre Hardy; Maria Febbraio; Pierre Lachapelle; Huy Ong; Florian Sennlaub; Sylvain Chemtob
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

9.  Split-spectrum amplitude-decorrelation angiography with optical coherence tomography.

Authors:  Yali Jia; Ou Tan; Jason Tokayer; Benjamin Potsaid; Yimin Wang; Jonathan J Liu; Martin F Kraus; Hrebesh Subhash; James G Fujimoto; Joachim Hornegger; David Huang
Journal:  Opt Express       Date:  2012-02-13       Impact factor: 3.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.